Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines

Vaccine

Volumn 18, Issue 22, 2000, Pages 2454-2461

  Burrage, T ^a   Kramer, E ^a   Brown, F ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Aziridines; Foot and mouth disease virus; Inactivation; Poliovirus

Indexed keywords

AZIRIDINE; AZIRIDINE DERIVATIVE; IMINE; N ACETYLETHYLENIMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CULTURE MEDIUM; ELECTRON MICROSCOPY; FOOT AND MOUTH DISEASE VIRUS; IN VITRO STUDY; IONIC STRENGTH; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TEMPERATURE; VIRUS INACTIVATION;

EID: 0034056632     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00542-3     Document Type: Article

References (21)

1. Moosbrugger G.A. Recherches experimentales sur la fievre aphteuse. Schweiz. Arch. Tierheilk. 90:1948;179-198.
2. Brown F., Crick J. Application of agar gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. J. Immun. 82:1959;444-447.
3. Brown F., Hyslop N.St.G., Crick J., Morrow A.W. The use of acetylethyleneimine in the production of an inactivated foot-and-mouth vaccine. J. Hyg. 61:1963;337-344.
4. Bahnemann H.G. Binary ethyleneimine as inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch. Virol. 47:1975;47-56.
5. King A.M.Q., Underwood B.O., McCahon D., Newman J.W.I., Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the U.K. Nature. 293:1981;479-480.
6. Beck E., Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61:1987;1621-1629.
7. Brown F., Meyer R.F., Law M., Kramer E., Newman J.F.E. A universal virus inactivant for decontaminating blood and biopharmaceutical products. Biologicals. 26:1998;39-47.
8. Bahnemann H.G. Inactivation of viruses in serum with binary ethyleneimine. J. Clin. Microbiol. 3:1976;209-210.
9. Brown F., Cartwright B. Purification of radio-active foot-and-mouth disease virus. Nature. 31:1963;1168-1170.
10. Graves J.H. Formaldehyde inactivation of foot-and-mouth disease virus as applied to vaccine preparation. Am. J. Vet. Res. 24:1963;1131-1135.
11. Ferguson M., Wood D.J., Minor P.D. Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. 74:1993;685-690.
12. Duque H., Marshall R.L., Israel B.A., Letchworth G.J. Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits. Vaccine. 7:1989;513-520.
13. Blackburn N.K., Besselaar T.G. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies. J. Virol. Methods. 33:1991;367-374.
14. Warrington R.J., Martens C.J., Rubin M., Rutherford W.J., Aoki F.Y. Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine. J. Allerg. Clin. Immun. 79:1987;605-610.
15. Bahnemann H.G. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethyleneimine. Vaccine. 8:1990;299-303.
16. Twomey T., Newman J., Burrage T., Lubroth J., Brown F. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines. Vaccine. 47:1995;1603-1610.
17. Breindl M. The structure of heated poliovirus particles. J. Gen. Virol. 11:1971;147-156.
18. Li Q., Yafal A.G., Lee Y.M.-H., Hogle J., Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 68:1994;3965-3970.
19. Rowlands D.J., Sangar D.V., Brown F. Buoyant density of picornaviruses in caesium salts. J. Gen. Virol. 13:1971;141-152.
20. Dermer O.C., Ham G.E. Ethyleneimine and other aziridines. 1969;Academic Press, New York.
21. Budowsky E.I., Zalesskaya M.A., Nepomnyashchaya N.M., Kostyanovsky R.G. Principles of selective inactivation of the viral genome: dependence of the rate of viral RNA modification on the number of protonizable groups in ethyleneimine oligomers. Vaccine Res. 5:1996;29-39.